Table 3 Hospital management of NAS, sample respondents in California Birth Hospitals in 2018.

From: Neonatal abstinence syndrome management in California birth hospitals: results of a statewide survey

Category

% distribution

95% CI

# of hospitals

First-line therapy for NAS care (n= 64)

  Nonpharmacologic interventions

97%

89%

100%

62

  Pharmacologic interventions

2%

0%

9%

1

  Other

2%

0%

9%

1

Frequency of nonpharmacologic management for NAS (n= 65)

  Always or usually

55%

43%

67%

36

  About half the time

18%

11%

30%

12

  Seldom or never

26%

17%

38%

17

Frequency of staying with mother for the infant's entire stay, among infants with nonpharmacologic management for NAS (n= 63)

  Always or usually

57%

45%

69%

36

  About half the time

8%

3%

18%

5

  Seldom or never

35%

24%

47%

22

Frequency of pharmacologic management for NAS (n= 68)

  Always or usually

49%

37%

60%

33

  About half the time

18%

10%

29%

12

  Seldom or never

34%

24%

46%

23

Frequency of staying with mother for the infant's entire stay, among infants with pharmacologic management for NAS (n= 58)

  Always or usually

7%

2%

17%

4

  About half the time

7%

2%

17%

4

  Seldom or never

86%

75%

93%

50

  1. Source: “Hospital Care and Emerging Practices for Treatment of Maternal Opioid Addiction, the Mother-Infant Dyad and Neonatal Abstinence Care: A Survey of California Hospitals” fielded June 2018 to August 2018 by the Urban Institute in collaboration with the California Perinatal Quality-Improvement Collaborative and the California Maternal Quality Care Collaborative
  2. n  = sample size. Denominator includes all respondents who selected a response in any part of the question (e.g., in a multi-item response table). A respondent who selected an answer in one line of the table but left another line blank are treated as “no” (instead of “missing”) for the line or lines for which they did not respond
  3. NAS neonatal abstinence syndrome, CI confidence interval